Skip to main content
Publications
van Kamp I, Waye KP, Kanninen K, Gulliver J, Bozzon A, Psyllidis A, Boshuizen H, Selander J, van den Hazel P, Brambilla M, Foraster M , Julvez J, Klatte M, Jeram S, Lercher P, Botteldooren D, Ristovska G, Kaprio J, Schreckenberg D, Hornikx M, Fels J, Weber M, Braat-Eggen E, Hartmann J, Clark C, Vrijkotte T, Brown L, Bolte G. Early environmental quality and life-course mental health effects: the equal-life project . Environ Epidemiol. 2021 Dec 16;6(1):e183. doi: 10.1097/EE9.0000000000000183
Shah R, Girard N, Nagar SP , Griesinger F, Roeper J, Davis KL , Karimi P, Sawyer W, Yu N, Taylor A, Feliciano J. European and US real-world treatment patterns in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer: a retrospective medical record review . Drugs Real World Outcomes. 2021 Dec;8(4):537-45. doi: 10.1007/s40801-021-00261-8
Wesselink AK, Kirwa K, Hatch EE, Hystad P, Szpiro AA, Kaufman JD, Levy JI, Mikkelsen EM, Quraishi SM, Rothman KJ , Wise LA. Residential proximity to major roads and fecundability in a preconception cohort . Environ Epidemiol. 2020 Nov 11;4(6):e112. doi: 10.1097/EE9.0000000000000112
Kuiper JG, van Herk-Sukel MPP, Castellsague J, Pottegard A, Berglind IA, Dedman D, Gutierrez L , Calingaert B , Hallas J, Sundstrom A, Gallagher AM, Kaye JA, Pardo C, Rothman KJ , Perez-Gutthann S . Use of topical tacrolimus and topical pimecrolimus in four European countries: a multicentre database cohort study . Drugs Real World Outcomes. 2018 Jun;5(2):109-16. doi: 10.1007/s40801-018-0133-1
Garcia-Albeniz X , Gallego R, Hofheinz RD, Fernandez-Esparrach G, Ayuso-Colella JR, Bombí JA, Conill C, Cuatrecasas M, Delgado S, Gines A, Miquel R, Pages M, Pineda E, Pereira Y, Sosa A, Reig O, Victoria I, Feliz L, María de Lacy A, Castells A, Burkholder I, Hochhaus A, Maurel J. Adjuvant therapy sparing in rectal cancer achieving complete response after chemoradiation . World J Gastroenterol. 2014 Nov 14;20(42):15820-9. doi: 10.3748/wjg.v20.i42.15820
Juhan-Vague I, Morange PE, Frere C, Aillaud MF, Alessi MC, Hawe E , Boquist S, Tornvall P, Yudkin JS, Tremoli E, Margaglione M, Di Minno G, Hamsten A, Humphries SE, HIFMECH Study Group. HIFMECH Study Group. The plasminogen activator inhibitor-1 -675 4G/5G genotype influences the risk of myocardial infarction associated with elevated plasma proinsulin and insulin concentrations in men from Europe: the HIFMECH study . J Thromb Haemost. 2003;1(11):2322-9.